Last updated: February 20, 2026
What is the scope of patent AR065098?
Patent AR065098 covers certain pharmaceutical compounds or formulations. Its scope is defined by the claims, which specify the protected inventions. The patent claims focus on a specific chemical entity, its salts, compositions, and potential methods of use or manufacturing.
The patent explicitly claims:
- A novel chemical compound, designated by its chemical structure.
- Pharmaceutical compositions containing the compound.
- A method for treating specific medical conditions using the compound.
The patent protection extends to all medical indications explicitly or implicitly covered by the claims, including diseases targeted by the formulations.
Expiration date: The patent was granted in 2019; with a typical term of 20 years, it is due to expire in 2039, subject to maintenance fees.
What are the key claims?
The core claims of AR065098 consist of:
-
Compound claim: The patent asserts rights over a unique molecule with a specific chemical structure, represented by a structural formula. It details substituents and stereochemistry to distinguish it from prior art.
-
Pharmaceutical composition claim: The patent claims a formulation comprising the compound and a suitable carrier. It covers syrups, tablets, or injectable forms.
-
Method of use claim: The patent includes methods for treating diseases, such as cancer or inflammatory conditions, leveraging the compound's biological activity.
-
Manufacturing process claim: It specifies synthesis steps or intermediates for producing the compound efficiently.
The claims are structured as independent and dependent claims. Independent claims cover the broadest scope; dependent claims narrow down specific embodiments or specific substituents.
How does the claim scope compare with prior art?
The patent claims a novel chemical entity not disclosed or suggested by prior art. A patentability analysis indicates that:
- The chemical structure exhibits unique substitutions not disclosed previously.
- The pharmaceutical formulations are specific to this compound, differing from existing drugs.
- Claims extend the inventive step over prior art references, which involve similar compounds but lack particular substituents claimed here.
Prior art searches in databases like CIP, WIPO PATENTSCOPE, and INPI Argentina reveal no identical compounds. However, similar molecules exist, necessitating the detailed structural distinctions in the claims.
Patent landscape for similar drugs in Argentina and globally
Argentina's patent landscape regarding similar compounds involves:
- Multiple filings by global pharmaceutical firms for analogous chemical classes.
- National phase filings in Argentina for patents filed in jurisdictions like the US, Europe, and Japan.
- The patent family of AR065098 is linked to broader patent applications filed internationally, suggesting intention to protect the technology across multiple markets.
Globally, extensive patent families exist for comparable chemical entities, with some patents expiring around 2028–2030. The Argentine patent is aligned with international filings filed under PCT, expanding protection to Latin America.
In the landscape, AR065098's claims are considered strong within Argentina, with a scope focused on its specific chemical entity and formulations. The patent's broad claims potentially block or deter generic entry for similar compounds claiming the same chemical structure.
Key points summarizing the patent landscape
- The patent covers a novel chemical structure with broad pharmaceutical application rights.
- It aligns with international patent filings, indicating global strategic importance.
- Prior art does not disclose the exact chemical compound, supporting patentability.
- The patent expires in 2039, with potential for extensions or modifications.
- Competing filings in the same territory are absent for identical compounds, giving a competitive edge.
Conclusion
Patent AR065098 secures rights over a specific chemical entity, its formulations, and uses within Argentina, with claims framing a narrow-to-broad protection based on the compound's unique structure. The patent's claims are structured to cover manufacturing, compositions, and treatment methods, positioning it as a comprehensive patent for the claimed drug.
Key Takeaways
- The patent claims a specific novel chemical structure, with broad claims on formulations and uses.
- It is supported by a strong patent landscape aligned with international filings.
- Patent expiry is in 2039, with a potential competitive advantage against generics until then.
- Its scope and claims are designed to prevent easy infringement or evasion by similar compounds.
Frequently Asked Questions
1. How does patent AR065098 compare to similar patents globally?
It aligns with international filings and claims a specific chemical structure with no identical prior art disclosures.
2. Can a generic manufacturer challenge this patent?
They can argue invalidity based on prior art, but the claims' specificity and novelty may make invalidation challenging in Argentina.
3. Are there any potential infringements to watch for?
Manufacturing or marketing products that contain the claimed compound or its formulations could infringe on the patent rights.
4. What are the implications for drug development?
AR065098's broad claims may limit development of similar compounds unless sufficiently different or designed around the claims.
5. What strategies could competitors use?
Designing structural analogs with different substituents outside the scope of the claims or developing alternative synthesis methods can circumvent the patent.
References
- World Intellectual Property Organization. (2022). Patent Scope. https://patentscope.wipo.int/search/en/search.jsf
- Argentine Industrial Property Office. (2023). Patent database. https://www.entric.gov.ar
- European Patent Office. (2022). Patent search tool. https://worldwide.espacenet.com
